Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.70
At close: May 22 EDT
$2.76
0.062.22%
Pre-Market: 7:13 AM EDT
Comments
Loading...
Solid Biosciences Analyst Ratings and Price Targets | NASDAQ:SLDB | Benzinga
Solid Biosciences Inc has a consensus price target of $15.25 based on the ratings of 16 analysts. The high is $40 issued by William Blair on March 28, 2024. The low is $5 issued by Cantor Fitzgerald on September 22, 2023. The 3 most-recent analyst ratings were released by Chardan Capital, Piper Sandler, and Wedbush on May 19, 2025, May 16, 2025, and May 16, 2025, respectively. With an average price target of $16.33 between Chardan Capital, Piper Sandler, and Wedbush, there's an implied 491.79% upside for Solid Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
Piper Sandler
Wedbush
Barclays
JP Morgan
1calculated from analyst ratings
Analyst Ratings for Solid Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/19/2025 | Buy Now | 443.48% | Chardan Capital | Geulah Livshits46% | $16 → $15 | Maintains | Buy | Get Alert |
| 05/16/2025 | Buy Now | 515.94% | Piper Sandler | Biren Amin38% | $20 → $17 | Maintains | Overweight | Get Alert |
| 05/16/2025 | Buy Now | 515.94% | Wedbush | Laura Chico45% | $18 → $17 | Maintains | Outperform | Get Alert |
| 05/16/2025 | Buy Now | 262.32% | Barclays | Gena Wang50% | $15 → $10 | Maintains | Overweight | Get Alert |
| 03/13/2025 | Buy Now | 298.55% | JP Morgan | Anupam Rama56% | $12 → $11 | Maintains | Overweight | Get Alert |
| 03/10/2025 | Buy Now | 624.64% | HC Wainwright & Co. | Arthur He33% | $16 → $20 | Maintains | Buy | Get Alert |
| 03/07/2025 | Buy Now | 479.71% | Chardan Capital | Geulah Livshits46% | $16 → $16 | Maintains | Buy | Get Alert |
| 03/07/2025 | Buy Now | 443.48% | Citizens Capital Markets | Silvan Tuerkcan47% | $15 → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 02/19/2025 | Buy Now | 479.71% | Chardan Capital | Geulah Livshits46% | $15 → $16 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2025 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 01/08/2025 | Buy Now | 479.71% | Truist Securities | Joon Lee76% | → $16 | Initiates | → Buy | Get Alert |
| 12/13/2024 | Buy Now | 479.71% | Wedbush | Laura Chico45% | → $16 | Initiates | → Outperform | Get Alert |
| 12/12/2024 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 12/10/2024 | Buy Now | 443.48% | JMP Securities | Silvan Tuerkcan47% | → $15 | Initiates | → Market Outperform | Get Alert |
| 11/12/2024 | Buy Now | 334.78% | JP Morgan | Anupam Rama56% | $15 → $12 | Maintains | Overweight | Get Alert |
| 11/11/2024 | Buy Now | 443.48% | Chardan Capital | Geulah Livshits46% | $15 → $15 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2024 | Buy Now | 443.48% | Barclays | Gena Wang50% | $18 → $15 | Maintains | Overweight | Get Alert |
| 08/14/2024 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 07/15/2024 | Buy Now | 443.48% | JP Morgan | Anupam Rama56% | $10 → $15 | Upgrade | Neutral → Overweight | Get Alert |
| 06/24/2024 | Buy Now | 334.78% | Leerink Partners | Joseph Schwartz64% | $12 → $12 | Upgrade | Market Perform → Outperform | Get Alert |
| 06/21/2024 | Buy Now | 624.64% | Piper Sandler | Biren Amin38% | $20 → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 05/31/2024 | Buy Now | 262.32% | JP Morgan | Anupam Rama56% | $12 → $10 | Maintains | Neutral | Get Alert |
| 05/20/2024 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 552.17% | Barclays | Gena Wang50% | $21 → $18 | Maintains | Overweight | Get Alert |
| 03/28/2024 | Buy Now | 1349.28% | William Blair | Tim Lugo33% | → $40 | Initiates | → Outperform | Get Alert |
| 03/18/2024 | Buy Now | 660.87% | Barclays | Gena Wang50% | $8 → $21 | Maintains | Overweight | Get Alert |
| 03/15/2024 | Buy Now | 479.71% | Citigroup | David Hoang42% | → $16 | Initiates | → Buy | Get Alert |
| 03/14/2024 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $16 → $16 | Reiterates | Buy → Buy | Get Alert |
| 03/14/2024 | Buy Now | 624.64% | Piper Sandler | Allison Bratzel68% | $8 → $20 | Upgrade | Neutral → Overweight | Get Alert |
| 03/11/2024 | Buy Now | 479.71% | HC Wainwright & Co. | Arthur He33% | $9 → $16 | Maintains | Buy | Get Alert |
| 12/08/2023 | Buy Now | 226.09% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $9 | Initiates | → Buy | Get Alert |
| 09/22/2023 | Buy Now | 81.16% | Cantor Fitzgerald | Charles Duncan68% | → $5 | Initiates | → Overweight | Get Alert |
| 11/11/2022 | Buy Now | 189.86% | Barclays | Gena Wang50% | $2 → $8 | Maintains | Overweight | Get Alert |
| 11/11/2022 | Buy Now | 189.86% | Piper Sandler | Allison Bratzel68% | $15 → $8 | Maintains | Neutral | Get Alert |
| 11/10/2022 | Buy Now | 117.39% | SVB Leerink | Joseph Schwartz64% | $1 → $6 | Maintains | Market Perform | Get Alert |
| 10/17/2022 | Buy Now | -63.77% | SVB Leerink | Joseph Schwartz64% | $12 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/30/2022 | Buy Now | — | JP Morgan | Anupam Rama56% | — | Upgrade | Underweight → Neutral | Get Alert |
| 08/12/2022 | Buy Now | 117.39% | Chardan Capital | Geulah Livshits46% | $7 → $6 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Solid Biosciences (SLDB) stock?
The latest price target for Solid Biosciences (NASDAQ:SLDB) was reported by Chardan Capital on May 19, 2025. The analyst firm set a price target for $15.00 expecting SLDB to rise to within 12 months (a possible 443.48% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Solid Biosciences (SLDB)?
The latest analyst rating for Solid Biosciences (NASDAQ:SLDB) was provided by Chardan Capital, and Solid Biosciences maintained their buy rating.
When was the last upgrade for Solid Biosciences (SLDB)?
The last upgrade for Solid Biosciences Inc happened on July 15, 2024 when JP Morgan raised their price target to $15. JP Morgan previously had a neutral for Solid Biosciences Inc.
When was the last downgrade for Solid Biosciences (SLDB)?
The last downgrade for Solid Biosciences Inc happened on October 17, 2022 when SVB Leerink changed their price target from $12 to $1 for Solid Biosciences Inc.
When is the next analyst rating going to be posted or updated for Solid Biosciences (SLDB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Solid Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Solid Biosciences was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.
Is the Analyst Rating Solid Biosciences (SLDB) correct?
While ratings are subjective and will change, the latest Solid Biosciences (SLDB) rating was a maintained with a price target of $16.00 to $15.00. The current price Solid Biosciences (SLDB) is trading at is $2.76, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
